Reaction
Pneumonia Mycoplasmal reporting signals
As of the last recalculation, Pneumonia Mycoplasmal appears in 785 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is CEFUROXIME (PRR 47.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cefuroxime | 20 | 47.6 | 47.7 |
| Clarithromycin | 37 | 29.9 | 30.0 |
| Selinexor | 8 | 24.7 | 24.8 |
| Ciclesonide | 12 | 23.7 | 23.7 |
| Canakinumab | 9 | 22.3 | 22.3 |
| Ketoconazole Foam | 11 | 20.0 | 20.0 |
| Ketoconazole Cream, 2% | 11 | 19.9 | 19.9 |
| Bendamustine Hcl | 10 | 17.3 | 17.3 |
| Oseltamivir | 5 | 16.8 | 16.8 |
| Ceftriaxone | 20 | 16.6 | 16.6 |
| Ceftriaxone Sodium | 23 | 16.4 | 16.4 |
| Azacitidine For | 8 | 11.8 | 11.8 |
| Vigabatrin | 6 | 11.0 | 11.0 |
| Carfilzomib | 10 | 9.5 | 9.5 |
| Bimekizumab | 4 | 5.0 | 5.0 |